Literature DB >> 3050094

Dysmorphic syndromes with demonstrable biochemical abnormalities.

P T Clayton1, E Thompson.   

Abstract

Many inborn errors of metabolism are associated with dysmorphic manifestations. In this review, we have attempted to correlate the dysmorphic features with the underlying metabolic defect or its consequences. Most of the defects which we have discussed affect the synthesis or degradation of macromolecules (for example, collagen, elastin, bone mineral, proteoglycans, glycoproteins, and triglycerides). Such defects may affect either a single enzyme or multiple enzymes in specific organelles, such as lysosomes or peroxisomes, or they may affect hormonal control of synthesis and degradation. Examples are also included of defects affecting the catabolism of simple molecules when accumulating metabolites have a secondary effect on macromolecules, as in homocystinuria. In a number of instances, however, the correlation between the biochemical abnormality and the dysmorphic features are not understood. Ultimately, all dysmorphic syndromes will be attributable to a biochemical defect or its effects. The aim of this overview is to provide an insight into the relationship between the two at the present time.

Entities:  

Mesh:

Year:  1988        PMID: 3050094      PMCID: PMC1050523          DOI: 10.1136/jmg.25.7.463

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  46 in total

1.  A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease.

Authors:  S R Pinnell; S M Krane; J E Kenzora; M J Glimcher
Journal:  N Engl J Med       Date:  1972-05-11       Impact factor: 91.245

2.  Alcohol and phenylketonuria.

Authors:  A H Lipson; J S Yu; M T O'Halloran; R Williams
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

3.  X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity.

Authors:  P H Byers; R C Siegel; K A Holbrook; A S Narayanan; P Bornstein; J G Hall
Journal:  N Engl J Med       Date:  1980-07-10       Impact factor: 91.245

4.  Homozygous osteogenesis imperfecta unlinked to collagen I genes.

Authors:  K Aitchison; D Ogilvie; M Honeyman; E Thompson; B Sykes
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

5.  Glutaric aciduria Type II.

Authors:  L Sweetman; W L Nyhan; D A Tauner; T A Merritt; M Singh
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

6.  Chondrodysplasia punctata--rhizomelic form. Pathologic and radiologic studies of three infants.

Authors:  E F Gilbert; J M Opitz; J W Spranger; L O Langer; J J Wolfson; C Viseskul
Journal:  Eur J Pediatr       Date:  1976-09-01       Impact factor: 3.183

7.  Partial lipodystrophy and familial C3 deficiency.

Authors:  R H McLean; D Hoefnagel
Journal:  Hum Hered       Date:  1980       Impact factor: 0.444

8.  beta-hydroxyisobutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations.

Authors:  G K Brown; S M Hunt; R Scholem; K Fowler; A Grimes; J F Mercer; R M Truscott; R G Cotton; J G Rogers; D M Danks
Journal:  Pediatrics       Date:  1982-10       Impact factor: 7.124

9.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.

Authors:  B Steinmann; L Tuderman; L Peltonen; G R Martin; V A McKusick; D J Prockop
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

View more
  2 in total

1.  Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey.

Authors:  J M Saudubray; H Ogier; J P Bonnefont; A Munnich; A Lombes; F Hervé; G Mitchel; B P Thé; N Specola; P Parvy
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Isolated dihydroxyacetonephosphate acyltransferase deficiency presenting with developmental delay.

Authors:  P T Clayton; S Eckhardt; J Wilson; C M Hall; Y Yousuf; R J Wanders; R B Schutgens
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.